1-6 of 6
Hellmut D. Ottinger
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

External validation of models for KIR2DS1/KIR3DL1-informed selection of hematopoietic cell donors fails

Clinical Trials & Observations
Johannes Schetelig, Henning Baldauf, Falk Heidenreich, Carolin Massalski, Sandra Frank, Jürgen Sauter, Matthias Stelljes, Francis Ayuketang Ayuk, Wolfgang A. Bethge, Gesine Bug, Stefan Klein, Sarah Wendler, Vinzenz Lange, Liesbeth C. de Wreede, Daniel Fürst, Guido Kobbe, Hellmut D. Ottinger, Dietrich W. Beelen, Joannis Mytilineos, Katharina Fleischhauer, Alexander H. Schmidt, Martin Bornhäuser
Journal: Blood
Blood (2020) 135 (16): 1386–1395.
https://doi.org/10.1182/blood.2019002887
Published: 2020
Includes: Supplemental data
Journal Articles

Functional distance between recipient and donor HLA-DPB1 determines nonpermissive mismatches in unrelated HCT

Pietro Crivello, Andreas Heinold, Vera Rebmann, Hellmut D. Ottinger, Peter A. Horn, Dietrich W. Beelen, Katharina Fleischhauer
Journal: Blood
Blood (2016) 128 (1): 120–129.
https://doi.org/10.1182/blood-2015-12-686238
Published: 2016
Includes: Supplemental data
Journal Articles

Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients

Ahmet H. Elmaagacli, Nina K. Steckel, Michael Koldehoff, Yael Hegerfeldt, Rudolf Trenschel, Markus Ditschkowski, Sandra Christoph, Tanja Gromke, Lambros Kordelas, Hellmut D. Ottinger, Rudolf S. Ross, Peter A. Horn, Susanne Schnittger, Dietrich W. Beelen
Journal: Blood
Blood (2011) 118 (5): 1402–1412.
https://doi.org/10.1182/blood-2010-08-304121
Published: 2011
Journal Articles

Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti–T-cell globulin ATG-Fresenius

Clinical Trials & Observations
Gérard Socié, Claudia Schmoor, Wolfgang A. Bethge, Hellmut D. Ottinger, Matthias Stelljes, Axel R. Zander, Liisa Volin, Tapani Ruutu, Dominik A. Heim, Rainer Schwerdtfeger, Karin Kolbe, Jiri Mayer, Johan A. Maertens, Werner Linkesch, Ernst Holler, Vladimir Koza, Martin Bornhäuser, Hermann Einsele, Hans-Jochem Kolb, Hartmut Bertz, Matthias Egger, Olga Grishina, Jürgen Finke, for the ATG-Fresenius Trial Group
Journal: Blood
Blood (2011) 117 (23): 6375–6382.
https://doi.org/10.1182/blood-2011-01-329821
Published: 2011
Includes: Supplemental data
Journal Articles

Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias

Clinical Trials & Observations
Dietrich W. Beelen, Hellmut D. Ottinger, Stanislav Ferencik, Ahmet H. Elmaagacli, Rudolf Peceny, Rudolf Trenschel, Hans Grosse-Wilde
Journal: Blood
Blood (2005) 105 (6): 2594–2600.
https://doi.org/10.1182/blood-2004-04-1441
Published: 2005
Journal Articles

Hematopoietic stem cell transplantation: contrasting the outcome of transplantations from HLA-identical siblings, partially HLA-mismatched related donors, and HLA-matched unrelated donors

Clinical Trials & Observations
Hellmut D. Ottinger, Stanislav Ferencik, Dietrich W. Beelen, Monika Lindemann, Rudolf Peceny, Ahmed H. Elmaagacli, Johannes Hüsing, Hans Grosse-Wilde
Journal: Blood
Blood (2003) 102 (3): 1131–1137.
https://doi.org/10.1182/blood-2002-09-2866
Published: 2003